ArticleAustralian veterinary journal2025
Systemic antibiotic use in fire-affected koalas (Phascolarctos cinereus) admitted to two wildlife treatment facilities during the 2019-2020 wildfires.
Article in Australian veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Detection of opportunistic bacterial pathogens with intrinsic amoxicillin- and cephalosporin-resistance in wild koala faecal microbiomes.Microbiology (Reading, England) · 2026Article
- Retrospective Analysis of Triage and Hospitalisation Records for Bushfire-Affected Koalas (Animals : an open access journal from MDPI · 2026Article
- Systemic antibiotic use in fire-affected koalas (Phascolarctos cinereus) admitted to two wildlife treatment facilities during the 2019-2020 wildfires.Australian veterinary journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Antimicrobial resistance (AMR) is a global health threat for people and animals, including wildlife. The overuse and misuse of antimicrobials continues to fuel the spread of AMR. We performed a retrospective analysis of systemic antibiotic administration in fire-affected koalas admitted to two wildlife treatment facilities during the catastrophic Australian wildfires in 2019-2020, to assess the practice of antimicrobial stewardship during a wildlife emergency. Triage and treatment records were obtained for fire-affected koalas (n = 355) admitted to two facilities during the wildfires. Analyses showed that 40.3% of koalas at Facility A and 35.0% of koalas at Facility B received systemic antibiotics. The majority of antibiotics (63.9%, comprising multiple types of beta-lactams) administered to koalas at Facility A were prophylactic treatments in koalas with noninfected moderate to severe cutaneous burn wounds. The majority of antibiotics (75.0%, comprising chloramphenicol and enrofloxacin) administered to koalas at Facility B were chlamydial disease treatments. Overall, 29.4% of all antibiotic treatments (predominantly beta-lactams and enrofloxacin) were administered for recorded clinical infections. Where koala-specific guidelines and protocols for treating burn wounds were not available, there was an overuse of systemic antibiotics and frequently sub-optimal antibiotic stewardship in burnt koalas during the 2019-2020 wildfire emergency response. Best practice antibiotic prescribing was also not always feasible due to a shortage of first-choice antibiotics (e.g., injectable chloramphenicol for chlamydial disease). This study highlights the importance of preparedness for future wildfire events and identifies a need for equipping veterinarians with guidelines for treating fire-affected koalas during emergency situations. Additional education, guidance and resources are required to enable appropriate antimicrobial stewardship by responding veterinarians during wildlife emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.